Single-Cell Gel (Comet) Assay Detects Primary DNA Damage in Nonneoplastic Urothelial Cells of Smokers and Ex-smokers1

  1. Álisson M. de M. C. Gontijo,
  2. Flávia N. Elias,
  3. Daisy M. F. Salvadori,
  4. Maria Luiza C. S. de Oliveira,
  5. Luis A. Correa,
  6. José Goldberg,
  7. José Carlos de S. Trindade and
  8. João Lauro V. de Camargo2
  1. Departamentos de Patologia [Á. M. de M. C. G., F. N. E., D. M. F. S., M. L. C. S. de O., J. L. V. de C.] and Urologia [L. A. C., J. G., J. C. de S. T.], Faculdade de Medicina, Universidade Estadual Paulista, 18618-000, Botucatu, São Paulo, Brazil.

    Abstract

    A protocol for DNA damage assessment by the single-cell gel (SCG)/comet assay in human urinary bladder washing cells was established. Modifications of the standard alkaline protocol included an increase to 2% of sodium sarcosinate in the lysis solution, a reduction in the glass-slide area for comet analysis, and a cutoff value for comet head diameter of at least 30 μm, to exclude contaminating leukocytes. Distinguishing cell populations is crucial, because significant differential migration was demonstrated for transitional and nontransitional cells, phenomena that may confound the results. When applying the modified protocol to urinary bladder cells from smokers without urinary bladder neoplasia, it was possible to detect a significant (P = 0.03) increase in DNA damage as depicted by the tail moment (6.39 ± 3.23; mean ± 95% confidence interval; n = 18) when compared with nonsmokers (1.94 ± 1.41; n = 12). No significant differences were observed between ex-smokers and current smokers regarding comet parameters. Inflammation was not a confounding factor, but DNA migration increased significantly with age in nonsmokers (r = 0.68; P = 0.014). Thus, age matching should be a concern when transitional cells are analyzed in the SCG assay. As it is well known, DNA damage may trigger genomic instability, a crucial step in carcinogenesis. Therefore, the present data directly support the classification of individuals with smoking history as patients at high risk for urinary bladder cancer.

    Footnotes

    • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • 1 Supported by Grants 99/01976-2 (to J. L. V. de C.) and 99/01095-6 (to F. N. E.) from the Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) and Grants 300705/81-6 (to J. L. V. de C.), 521893/97-6 (to D. M. F. S.), 830850/99-6 (to Á. M. de M. C. G.) from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil.

    • 2 To whom requests for reprints should addressed, at Departamento de Patologia, Faculdade de Medicina, UNESP, Rubião Jr. s/n, 18618-000, Botucatu, São Paulo, Brazil. E-mail: decam{at}fmb.unesp.br

    • 3 The abbreviation used is: SCG, single cell gel.

    • 4 Unpublished observations.

    • 5 Á. M. de M. C. Gontijo and D. M. F. Salvadori, unpublished observations.

    • 6 R. R. Tice, personal communication.

      • Accepted June 19, 1901.
      • Received February 23, 1901.
      • Revision received May 25, 1901.
    « Previous | Next Article »Table of Contents